Dear AABB attendees,



Visit our exhibit booth 
Grifols Diagnostic Solutions is proud to continue supporting safe and compatible blood transfusion. Our commitment has never changed to deliver an innovative portfolio of transfusion medicine products designed for today's healthcare needs. 
We had hoped to be together with you at AABB 2021, sharing ideas and reconnecting, but we are grateful for the opportunity to be with you virtually. We invite you to visit our virtual booth and learn more about our efforts to improve the health and well-being of patients around the world.


Company Overview

Grifols is a global healthcare company that since its founding in Barcelona in 1909 has enhanced the health and well-being of people around the world. Our four divisions – Bioscience, Diagnostic, Hospital, and Bio Supplies – develop, produce, and market innovative solutions and services in more than 100 countries.

As a recognized leader in transfusion medicine, the Diagnostic division shares the commitment to increase transfusion safety from donation to transfusion. The division offers a comprehensive portfolio, while helping to manage and simplify laboratory operations. Additionally, the division offers a portfolio of specialized clinical diagnostics focused on select therapeutic areas.

Grifols, with more than 24,000 employees in 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety, and ethical leadership in the industry.



History Driven By Innovation

Grifols has more than 100 years of experience and knowledge in the field of transfusion medicine. Today based on this knowledge and experience we offer a full range of diagnostic solutions designed to meet your needs. 
Learn more about our history

A Global Leader In Transfusion Medicine

Over 32M units of blood are screened utilizing Grifols products yearly. Every day Grifols advances transfusion safety through our:

  • Leadership: We apply our extensive global expertise across the transfusion continuum.
  • Commitment: Grifols continues to strives towards ensuring safety within the transfusion chain, from donor to patient. It's in the Grifols DNA.
  • Partnership: How we work is just as important as what we deliver. Whether your center needs educational mentorship, expert workflow design, implementation support, user training or timely technical service, you have a partner that delivers support you can count on.

Supporting Decision Making Across The Healthcare Continuum


  • Blood and plasma infectious disease screening

  • Donor and patient blood compatibility typing

  • Antigen manufacturing


  • Infectious disease

  • Autoimmunity

  • Neurodegenerative


  • Blood clotting and thrombosis risk


  • Autoimmunity testing

  • Biological drug monitoring

  • Treatment monitoring for blood thinner

This information is intended for physicians and healthcare professionals only.
Product registration and availability vary by country. For more information on product availability, please contact us here.